• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The importance of contextually specific support relationships in implementing programs to link people to medication for opioid use disorder (MOUD) treatment during reentry from county jails.在从县监狱重新进入社会期间实施将人们与阿片类药物使用障碍(MOUD)治疗药物联系起来的项目时,因地制宜的支持关系的重要性。
Health Justice. 2025 Mar 31;13(1):20. doi: 10.1186/s40352-025-00330-y.
2
Systems analysis and improvement to optimize opioid use disorder care quality and continuity for patients exiting jail (SAIA-MOUD).系统分析与改进,以优化出狱患者阿片类药物使用障碍护理的质量和连续性(SAIA-MOUD)。
Implement Sci. 2024 Dec 18;19(1):80. doi: 10.1186/s13012-024-01409-0.
3
Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts.基于监狱的重新融入计划,以支持继续使用药物治疗阿片类药物使用障碍:马萨诸塞州监狱工作人员的定性观点和经验。
Int J Drug Policy. 2022 Nov;109:103823. doi: 10.1016/j.drugpo.2022.103823. Epub 2022 Aug 19.
4
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative.监禁环境下阿片类药物使用障碍治疗在保释改革时代:一项州范围药物治疗计划实施的障碍和促进因素的定性研究。
Addict Sci Clin Pract. 2022 Jun 2;17(1):30. doi: 10.1186/s13722-022-00313-6.
5
Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers.出狱后治疗阿片类药物使用障碍的药物治疗连续性:一项基于社区的治疗提供者的定性研究。
Int J Drug Policy. 2022 Dec;110:103803. doi: 10.1016/j.drugpo.2022.103803. Epub 2022 Aug 11.
6
Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.扩大监狱中阿片类药物使用障碍(MOUD)药物的获取途径:一项综合项目评估。
J Subst Use Addict Treat. 2024 Jun;161:209248. doi: 10.1016/j.josat.2023.209248. Epub 2023 Dec 9.
7
Patient perspectives of jail based MOUD treatment: views of individuals who have returned to the community following incarceration.基于监狱的药物辅助治疗的患者观点:曾被监禁后重返社区的个人的看法。
Health Justice. 2025 Apr 22;13(1):25. doi: 10.1186/s40352-025-00319-7.
8
Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails.与美国监狱中阿片类药物使用障碍药物供应相关的因素。
JAMA Netw Open. 2024 Sep 3;7(9):e2434704. doi: 10.1001/jamanetworkopen.2024.34704.
9
Rapid jail-based implementation of overdose education and naloxone distribution in response to the COVID-19 pandemic.为应对新冠疫情,在监狱中迅速实施过量用药教育及纳洛酮分发工作。
Health Justice. 2024 Jun 27;12(1):27. doi: 10.1186/s40352-024-00283-8.
10
Cost analysis of MOUD implementation and sustainability in Massachusetts jails.马萨诸塞州监狱中药物辅助治疗(MOUD)实施与可持续性的成本分析
Health Justice. 2025 Feb 5;13(1):9. doi: 10.1186/s40352-025-00321-z.

本文引用的文献

1
Underuse of Lifesaving Medications for Opioid Use Disorder in US Jails.美国监狱中用于阿片类药物使用障碍的救命药物使用不足。
JAMA Netw Open. 2024 Sep 3;7(9):e2434649. doi: 10.1001/jamanetworkopen.2024.34649.
2
Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails.与美国监狱中阿片类药物使用障碍药物供应相关的因素。
JAMA Netw Open. 2024 Sep 3;7(9):e2434704. doi: 10.1001/jamanetworkopen.2024.34704.
3
Rapid jail-based implementation of overdose education and naloxone distribution in response to the COVID-19 pandemic.为应对新冠疫情,在监狱中迅速实施过量用药教育及纳洛酮分发工作。
Health Justice. 2024 Jun 27;12(1):27. doi: 10.1186/s40352-024-00283-8.
4
Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study.阿片类物质使用障碍的监狱内药物治疗与社区持续治疗之间的照护过渡:一项回顾性队列研究。
Drug Alcohol Depend. 2024 Aug 1;261:111377. doi: 10.1016/j.drugalcdep.2024.111377. Epub 2024 Jun 24.
5
Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.基于社区的整群随机试验以减少阿片类药物过量死亡
N Engl J Med. 2024 Sep 19;391(11):989-1001. doi: 10.1056/NEJMoa2401177. Epub 2024 Jun 16.
6
Embedding Big Qual and Team Science into Qualitative Research: Lessons from a Large-scale, Cross-site Research Study.将大规模质性研究与团队科学融入质性研究:来自一项大规模跨站点研究的经验教训
Int J Qual Methods. 2023 Jan-Dec;22. doi: 10.1177/16094069231165933. Epub 2023 Jun 5.
7
The development of a recovery coaching training curriculum to facilitate linkage to and increase retention on medications for opioid use disorder.制定一项康复教练培训课程,以促进阿片类药物使用障碍患者药物治疗的衔接和保持率。
Front Public Health. 2024 Feb 15;12:1334850. doi: 10.3389/fpubh.2024.1334850. eCollection 2024.
8
The association between attitudes and the provision of medications for opioid use disorder (MOUD) in United States jails.美国监狱中态度与阿片类药物使用障碍药物治疗(MOUD)供应之间的关联。
Drug Alcohol Depend Rep. 2023 Dec 14;10:100211. doi: 10.1016/j.dadr.2023.100211. eCollection 2024 Mar.
9
Get It in Writing: How to Make Medications for Opioid Use Disorder Available During Incarceration.书面记录:如何在监禁期间提供阿片类药物使用障碍治疗药物。
J Correct Health Care. 2024 Feb;30(1):3-6. doi: 10.1089/jchc.23.08.0065. Epub 2023 Dec 26.
10
Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.扩大监狱中阿片类药物使用障碍(MOUD)药物的获取途径:一项综合项目评估。
J Subst Use Addict Treat. 2024 Jun;161:209248. doi: 10.1016/j.josat.2023.209248. Epub 2023 Dec 9.

在从县监狱重新进入社会期间实施将人们与阿片类药物使用障碍(MOUD)治疗药物联系起来的项目时,因地制宜的支持关系的重要性。

The importance of contextually specific support relationships in implementing programs to link people to medication for opioid use disorder (MOUD) treatment during reentry from county jails.

作者信息

McGladrey Margaret, Booty Marisa, Stitzer Susannah, Knudsen Hannah K, Walsh Sharon L, Goetz Michael, Mattingly Hallie, Lofwall Michelle, Fanucchi Laura, Oller Devin, Fallin-Bennett Amanda, Oser Carrie B

机构信息

University of Kentucky, Lexington, USA.

出版信息

Health Justice. 2025 Mar 31;13(1):20. doi: 10.1186/s40352-025-00330-y.

DOI:10.1186/s40352-025-00330-y
PMID:40163160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11956208/
Abstract

BACKGROUND

This study uses the Practical, Robust, Implementation, and Sustainability Model (PRISM) and Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) model to describe how features of jail contexts are associated with the number of people linked to medication for opioid use disorder (MOUD) and sustainment of jail linkage programs implemented in Wave 1 of the HEALing Communities Study in Kentucky (HCS-KY) from 2021 to 22. The HCS-KY is part of a parallel-group, cluster-randomized wait-list controlled trial examining the effects of supporting wide-scale implementation of evidence-based practices to reduce opioid overdose deaths. One strategy involved implementation of MOUD linkage programs within five Kentucky county jails. Minutes from program planning and maintenance meetings led by HCS-KY implementation facilitators with linkage staff/supervisors and jail liaisons/partners (average of five participants/meeting) were coded following PRISM-RE-AIM using template analysis to understand variations in participation across sites as well as barriers to and facilitators of MOUD linkage implementation.

RESULTS

Across the five jails, 277 participants met with linkage staff during and/or post-incarceration for 1,119 visits conducted in-person or via phone/video conference. Twenty-six participants linked to community-based MOUD treatment during the implementation period. Participation differed across sites based on jail and linkage staff utilization of implementation support strategies but did not affect program sustainment, which all jails pursued in some form. Qualitative analysis yielded four overarching themes characterizing jail linkage program implementation. First, program integration into jail infrastructure entailed navigation of jail facilities and technologies as well as legal factors surrounding linkage staff backgrounds and information-sharing. Second, adapting the intervention to site-specific needs required providing training and implementation support to jail and linkage staff tailored to each jail context. Third, facilitating inter-organizational and cross-system coordination was related to collaboration successes and challenges among the HCS-KY team, linkage staff, the courts, and other provider partners. Finally, staffing and legal factors influenced sustainment.

CONCLUSIONS

Only ~ 10% of participants linked to community-based MOUD despite intensive implementation support, yet jails highly valued the program and planned for sustainment. Given the complexities in postponing treatment initiation until reentry, we call for simultaneous efforts to integrate MOUD screening and treatment into jail booking processes.

摘要

背景

本研究使用实用、稳健、实施与可持续性模型(PRISM)以及覆盖、效果、采用、实施与维持模型(RE-AIM)来描述监狱环境特征与与阿片类药物使用障碍药物治疗(MOUD)相关联的人数之间的关系,以及2021年至2022年在肯塔基州开展的治愈社区研究(HCS-KY)第一阶段实施的监狱联系项目的持续性。HCS-KY是一项平行组、整群随机等待列表对照试验的一部分,该试验考察支持广泛实施循证实践以减少阿片类药物过量死亡的效果。其中一项策略是在肯塔基州的五个县监狱内实施MOUD联系项目。由HCS-KY实施促进者与联系工作人员/主管以及监狱联络人/合作伙伴(平均每次会议五名参与者)主持的项目规划和维护会议记录,按照PRISM-RE-AIM使用模板分析进行编码,以了解各地点参与情况的差异以及MOUD联系实施的障碍和促进因素。

结果

在这五个监狱中,277名参与者在监禁期间和/或监禁后与联系工作人员会面,进行了1119次面对面或通过电话/视频会议的探访。在实施期间,有26名参与者与社区MOUD治疗建立了联系。各地点的参与情况因监狱和联系工作人员对实施支持策略的利用情况而异,但不影响项目的持续性,所有监狱都以某种形式追求项目的持续性。定性分析产生了四个总体主题,描述了监狱联系项目的实施情况。第一,将项目整合到监狱基础设施中需要在监狱设施和技术方面进行导航,以及处理与联系工作人员背景和信息共享相关的法律因素。第二,可以根据具体地点的需求调整干预措施,需要为每个监狱环境的监狱和联系工作人员提供量身定制的培训和实施支持。第三,促进组织间和跨系统协调与HCS-KY团队、联系工作人员、法院和其他提供者合作伙伴之间的合作成功与挑战有关。最后,人员配备和法律因素影响持续性。

结论

尽管得到了大力的实施支持,但只有约10%的参与者与社区MOUD建立了联系,然而监狱高度重视该项目并计划维持该项目。鉴于推迟治疗开始直至重新进入社会存在复杂性,我们呼吁同时努力将MOUD筛查和治疗纳入监狱登记程序。